WNT PATHWAY

Clinical trials for WNT PATHWAY explained in plain language.

Never miss a new study

Get alerted when new WNT PATHWAY trials appear

Sign up with your email to follow new studies for WNT PATHWAY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug FOG-001 targets Hard-to-Treat cancers in early trial

Disease control Recruiting now

This study tests a new drug, FOG-001, in about 595 people with advanced solid tumors that have not responded to other treatments. The goal is to see if FOG-001 is safe and can shrink tumors or slow their growth. The trial focuses on several cancer types, including colorectal, pro…

Matched conditions: WNT PATHWAY

Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control

Last updated May 11, 2026 20:46 UTC

WNT PATHWAY

Get alerted when new WNT PATHWAY trials appear

New drug FOG-001 targets Hard-to-Treat cancers in early trial